IN2015DN00138A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN00138A IN2015DN00138A IN138DEN2015A IN2015DN00138A IN 2015DN00138 A IN2015DN00138 A IN 2015DN00138A IN 138DEN2015 A IN138DEN2015 A IN 138DEN2015A IN 2015DN00138 A IN2015DN00138 A IN 2015DN00138A
- Authority
- IN
- India
- Prior art keywords
- library
- human germline
- antibody chains
- germline antibody
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695819P | 2012-08-31 | 2012-08-31 | |
| PCT/EP2013/068110 WO2014033304A2 (en) | 2012-08-31 | 2013-09-02 | Highly diverse combinatorial antibody libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN00138A true IN2015DN00138A (es) | 2015-06-12 |
Family
ID=49117845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN138DEN2015 IN2015DN00138A (es) | 2012-08-31 | 2013-09-02 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10040870B2 (es) |
| EP (1) | EP2890709A2 (es) |
| JP (1) | JP6283030B2 (es) |
| CN (1) | CN104583236A (es) |
| AU (1) | AU2013310839B2 (es) |
| CA (1) | CA2879834A1 (es) |
| IL (1) | IL236524B (es) |
| IN (1) | IN2015DN00138A (es) |
| WO (1) | WO2014033304A2 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9708412B2 (en) | 2015-05-21 | 2017-07-18 | Harpoon Therapeutics, Inc. | Trispecific binding proteins and methods of use |
| WO2017201493A1 (en) | 2016-05-20 | 2017-11-23 | Harpoon Therapeutics, Inc. | Single chain variable fragment cd3 binding proteins |
| EP3493844A4 (en) | 2016-05-20 | 2021-03-24 | Harpoon Therapeutics Inc. | SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN |
| US11623958B2 (en) | 2016-05-20 | 2023-04-11 | Harpoon Therapeutics, Inc. | Single chain variable fragment CD3 binding proteins |
| WO2018007999A1 (en) | 2016-07-08 | 2018-01-11 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
| AU2017363300A1 (en) | 2016-11-23 | 2019-06-20 | Harpoon Therapeutics, Inc. | Prostate specific membrane antigen binding protein |
| WO2018098356A1 (en) * | 2016-11-23 | 2018-05-31 | Harpoon Therapeutics, Inc. | Psma targeting trispecific proteins and methods of use |
| WO2018103093A1 (zh) * | 2016-12-09 | 2018-06-14 | 深圳华大基因研究院 | 骆驼科抗体可变区免疫组库构建的引物组合及应用 |
| US11535668B2 (en) | 2017-02-28 | 2022-12-27 | Harpoon Therapeutics, Inc. | Inducible monovalent antigen binding protein |
| CN110506056A (zh) | 2017-04-21 | 2019-11-26 | 斯塔滕生物技术有限公司 | 抗apoc3抗体和其使用方法 |
| WO2018209304A1 (en) | 2017-05-12 | 2018-11-15 | Harpoon Therapeutics, Inc. | Msln targeting trispecific proteins and methods of use |
| EP3621994A4 (en) | 2017-05-12 | 2020-12-30 | Harpoon Therapeutics, Inc. | MESOTHELIN BINDING PROTEINS |
| MX2020003915A (es) | 2017-10-13 | 2020-10-08 | Harpoon Therapeutics Inc | Proteinas trispecificas y metodos de uso. |
| IL315737A (en) | 2017-10-13 | 2024-11-01 | Harpoon Therapeutics Inc | B-cell maturation antigen-binding proteins |
| PE20210119A1 (es) | 2017-10-31 | 2021-01-19 | Staten Biotechnology B V | Anticuerpos anti-apoc3 y metodos de uso de estos |
| BR112020023330A2 (pt) | 2018-05-14 | 2021-04-20 | Harpoon Therapeutics, Inc. | porção de ligação para ativação condicional de moléculas de imunoglobulina |
| US12195544B2 (en) | 2018-09-21 | 2025-01-14 | Harpoon Therapeutics, Inc. | EGFR binding proteins and methods of use |
| US10815311B2 (en) | 2018-09-25 | 2020-10-27 | Harpoon Therapeutics, Inc. | DLL3 binding proteins and methods of use |
| AU2020275002A1 (en) | 2019-05-14 | 2021-12-23 | Harpoon Therapeutics, Inc. | EpCAM binding proteins and methods of use |
| CN115768463A (zh) | 2020-02-21 | 2023-03-07 | 哈普恩治疗公司 | Flt3结合蛋白及使用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| US8444976B2 (en) * | 2008-07-02 | 2013-05-21 | Argen-X B.V. | Antigen binding polypeptides |
| GB2461546B (en) * | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| CN102459591B (zh) * | 2009-05-20 | 2015-05-13 | 诺维莫尼公司 | 合成性的多肽文库以及用于建立具有天然多样性的多肽变体的方法 |
| GB2476681B (en) | 2010-01-04 | 2012-04-04 | Argen X Bv | Humanized camelid VH, VK and VL immunoglobulin domains |
-
2013
- 2013-09-02 US US14/419,881 patent/US10040870B2/en active Active
- 2013-09-02 JP JP2015529046A patent/JP6283030B2/ja active Active
- 2013-09-02 AU AU2013310839A patent/AU2013310839B2/en active Active
- 2013-09-02 WO PCT/EP2013/068110 patent/WO2014033304A2/en not_active Ceased
- 2013-09-02 EP EP13758830.7A patent/EP2890709A2/en not_active Withdrawn
- 2013-09-02 CN CN201380044638.9A patent/CN104583236A/zh active Pending
- 2013-09-02 CA CA2879834A patent/CA2879834A1/en not_active Abandoned
- 2013-09-02 IN IN138DEN2015 patent/IN2015DN00138A/en unknown
-
2014
- 2014-12-31 IL IL236524A patent/IL236524B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN104583236A (zh) | 2015-04-29 |
| AU2013310839B2 (en) | 2017-06-01 |
| WO2014033304A2 (en) | 2014-03-06 |
| JP6283030B2 (ja) | 2018-02-21 |
| IL236524A0 (en) | 2015-02-26 |
| JP2015526495A (ja) | 2015-09-10 |
| WO2014033304A3 (en) | 2014-05-01 |
| IL236524B (en) | 2019-01-31 |
| AU2013310839A1 (en) | 2015-01-29 |
| CA2879834A1 (en) | 2014-03-06 |
| US20150166680A1 (en) | 2015-06-18 |
| EP2890709A2 (en) | 2015-07-08 |
| US10040870B2 (en) | 2018-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN00138A (es) | ||
| IN2014DN08163A (es) | ||
| CY1121832T1 (el) | Μονοκλωνικα αντισωματα κατα του παραγοντα αναπτυξεως και διαφοροποιησεως 15(gdf-15) | |
| PH12017500819A1 (en) | Cd3/cd38 t cell retargeting hetero-dimeric immunoglobulins and methods of their production | |
| MX2021003704A (es) | Anticuerpos heterodimericos que se unen a cd3 y a antigenos tumorales. | |
| MX353609B (es) | Animales no humanos que expresan anticuerpos que tienen una cadena ligera comun. | |
| PH12015502293A1 (en) | Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use | |
| EA201790043A1 (ru) | Наноносители, вырабатывающие иммунную толерантность, для вырабатывания cd8+ регуляторных т-клеток | |
| NZ629296A (en) | Humanized antibodies that recognize alpha-synuclein | |
| PH12014501427B1 (en) | Anti-phf-tau antibodies and their uses | |
| EA201591113A1 (ru) | Антитела против антигена 2 дендритных клеток крови и их применение | |
| SG10201909806SA (en) | Production of t cell retargeting hetero-dimeric immunoglobulins | |
| EP3388449A3 (en) | Cysteine engineered antibodies and conjugates | |
| MX2015010427A (es) | Anticuerpos anti-tnf-alfa altamente galactosilados y sus usos. | |
| MX349662B (es) | Anticuerpos de antigenos antitumorales y metodos de uso. | |
| NZ705606A (en) | Methods for identifying antibodies with reduced immunogenicity | |
| MX2015012540A (es) | Ratón de cadena ligera común. | |
| IN2014CN03572A (es) | ||
| EA201400875A1 (ru) | Антитела к cd47 и способы их применения | |
| GB2525568A (en) | Single cell bar-coding for antibody discovery | |
| UY34343A (es) | Proteinas de unión al antígeno cd27l | |
| MX2020010837A (es) | Ratones que expresan un repertorio limitado de cadena ligera de inmunoglobulina. | |
| IL241433B (en) | A protocol for identifying and isolating antigens specific to b cells and creating antibodies to desired antigens | |
| NZ703973A (en) | Complex chromosome engineering for production of human antibodies in transgenic animals | |
| PH12013500933A1 (en) | Methods and compositions for neural disease immunotherapy |